Last reviewed · How we verify

Silymarin (Silybum marianum) — Competitive Intelligence Brief

Silymarin (Silybum marianum) (Silymarin (Silybum marianum)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal extract / Antioxidant. Area: Hepatology / Gastroenterology.

marketed Herbal extract / Antioxidant Hepatology / Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Silymarin (Silybum marianum) (Silymarin (Silybum marianum)) — University of Maryland, Baltimore. Silymarin is a flavonolignan mixture that protects liver cells by acting as an antioxidant and anti-inflammatory agent, stabilizing cell membranes and inhibiting toxin uptake.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Silymarin (Silybum marianum) TARGET Silymarin (Silybum marianum) University of Maryland, Baltimore marketed Herbal extract / Antioxidant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal extract / Antioxidant class)

  1. University of Maryland, Baltimore · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Silymarin (Silybum marianum) — Competitive Intelligence Brief. https://druglandscape.com/ci/silymarin-silybum-marianum. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: